Regarding the industry's talent pipeline, Dr. de Miguel highlights the importance of education programs in the fields of science, technology, engineering, and mathematics (STEM) in building the ...

FDA orphan designation for zenocutuzumab‑zbco targets NRG1 fusion–positive advanced cholangiocarcinoma, a small molecular subset within an aggressive malignancy with <15% five-year survival. Orphan ...

Gov. Kim Reynolds announced Thursday she was introducing legislation that would increase taxes on cigarettes and tobacco ...

The disease remains one of the leading causes of death among women, but it could become the first cancer to be eradicated ...

A new breakthrough in the pathology of glioblastoma – the most common type of brain cancer, currently incurable – has been ...

Amgen added to uncertainty surrounding the OX40 drug class by returning an autoimmune candidate to Kyowa Kirin. | Amgen added ...

Human papillomavirus (HPV) is the causative agent of chronic papillomavirus infection. Some of them can lead to the ...

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical ...

Member of Parliament Hema Malini met Delhi Chief Minister Rekha Gupta at the Delhi Secretariat on Thursday, where the two ...

Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...

Explore how biochemistry, microbiology, and pathology collaborate in cancer care for early detection, personalized treatment, and survival monitoring.

Melissa B. Davis uses CRISPR screening to better understand how cancer affects underrepresented populations and find new potential therapeutic targets.